The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElixirr International Regulatory News (ELIX)

Share Price Information for Elixirr International (ELIX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 570.00
Bid: 560.00
Ask: 580.00
Change: 0.00 (0.00%)
Spread: 20.00 (3.571%)
Open: 570.00
High: 570.00
Low: 570.00
Prev. Close: 570.00
ELIX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

8 Apr 2022 16:15

RNS Number : 8526H
Elixirr International PLC
08 April 2022
 

ELIXIRR INTERNATIONAL PLC

("Elixirr", the "Company" or the "Group")

Director / PDMR Shareholdings

Elixirr International plc (AIM:ELIX), an established, global award-winning challenger consultancy, announces that, following the announcement made on the 18 March 2022 regarding the acquisition of iOLAP Incorporated ("iOLAP"), the Company will be satisfying the initial share consideration through a sale from the Employee Benefit Trust ("EBT"), in order to avoid the dilution of existing shareholders.

In order to provide the EBT with sufficient shares to facilitate the initial share consideration, certain Directors, PDMRs and shareholders have today notified the Company of the sale of shares to the EBT, each at a price of 765p (being the closing share price on 5 April 2022). Sales by Directors and PDMRs are as follows:

 

Name

Position

No. of Ordinary Shares sold

Resulting holding of Ordinary Shares

Resulting % holding in the Company

Stephen Newton

Founder & CEO

653,595

13,346,238

28.9

Graham Busby

CFO

36,666

1,429,972

3.1

Ian Ferguson

General Counsel

66,239

2,594,082

5.6

Eric Rich

Partner (PDMR)

17,727

691,355

1.5

Brandon Bichler

Partner (PDMR)

17,815

694,788

1.5

Clare Filby

COO (PDMR)

13,743

541,901

1.2

Nicholas Willott

Finance Director (PDMR)

6,321

270,824

0.6

 

As detailed in the announcement of 18 March 2022, the sellers of iOLAP are subject to a contractual commitment to use US$11.2 million of the initial consideration less tax to purchase shares in Elixirr from the EBT at a price per share of 642.5p (being the closing share price on 16 March 2022) by 29 April 2022.

For further Information please contact:

 

Elixirr International plc

 

Stephen Newton, CEO

 

Graham Busby, CFO

 

 

 

 

Public and Investor Relations contacts:

Caroline Pitt

 

 

finnCap Ltd (Nominated Adviser & Sole Broker)

 

Christopher Raggett / Kate Bannatyne (Corporate Finance)

 

Alice Lane / Sunila De Silva (ECM)

 

 

investor-relations@elixirr.com

 

 

 

 

+44 (0)20 7220 0500

 

 

About Elixirr International plc

Elixirr is an established global award-winning management consultancy, challenging the larger consultancies by delivering innovative and bespoke solutions to a repeat, globally-recognised client base.

Elixirr was founded in 2009, by Stephen Newton, Graham Busby, Ian Ferguson, Andy Curtis and Mark Goodyear, experienced business advisors who identified a market opportunity to provide bespoke, personal services as a 'challenger' to the traditional consultancy businesses in the market. Elixirr guides its clients to overcome challenges such as: future-proofing against technological disruption; development and roll-out of new propositions, products and services; incubating new businesses; navigating a more complex and multinational regulatory environment; and project management and implementation of major change programmes.

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Stephen Newton

2.

Reason for the Notification

a)

Position/status

Founder & CEO

b)

Initial notification/Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Elixirr International plc

b)

LEI

213800MKY7OHMVAKW681

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 0.005p each ("Ordinary Shares")

Identification code

GB00BLPHTX84

b)

Nature of the transaction

Sale of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

765p

653,595

d)

Aggregated information:

 

653,595 shares at 765p

 

e)

Date of the transaction

08 April 2022

f)

Place of the transaction

London Stock Exchange, AIM market (XLON)

 

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Graham Busby

3.

Reason for the Notification

a)

Position/status

CFO

b)

Initial notification/Amendment

Initial Notification

4.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Elixirr International plc

b)

LEI

213800MKY7OHMVAKW681

5.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 0.005p each ("Ordinary Shares")

Identification code

GB00BLPHTX84

b)

Nature of the transaction

Sale of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

765p

36,666

d)

Aggregated information:

 

36,666 shares at 765p

 

e)

Date of the transaction

08 April 2022

f)

Place of the transaction

London Stock Exchange, AIM market (XLON)

 

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Ian Ferguson

4.

Reason for the Notification

a)

Position/status

General Counsel

b)

Initial notification/Amendment

Initial Notification

5.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Elixirr International plc

b)

LEI

213800MKY7OHMVAKW681

6.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 0.005p each ("Ordinary Shares")

Identification code

GB00BLPHTX84

b)

Nature of the transaction

Sale of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

765p

66,239

d)

Aggregated information:

 

66,239 shares at 765p

 

e)

Date of the transaction

08 April 2022

f)

Place of the transaction

London Stock Exchange, AIM market (XLON)

 

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Eric Rich

5.

Reason for the Notification

a)

Position/status

PDMR

b)

Initial notification/Amendment

Initial Notification

6.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Elixirr International plc

b)

LEI

213800MKY7OHMVAKW681

7.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 0.005p each ("Ordinary Shares")

Identification code

GB00BLPHTX84

b)

Nature of the transaction

Sale of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

765p

17,727

d)

Aggregated information:

 

17,727 shares at 765p

 

e)

Date of the transaction

08 April 2022

f)

Place of the transaction

London Stock Exchange, AIM market (XLON)

 

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Brandon Bichler

6.

Reason for the Notification

a)

Position/status

PDMR

b)

Initial notification/Amendment

Initial Notification

7.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Elixirr International plc

b)

LEI

213800MKY7OHMVAKW681

8.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 0.005p each ("Ordinary Shares")

Identification code

GB00BLPHTX84

b)

Nature of the transaction

Sale of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

765p

17,815

d)

Aggregated information:

 

17,815 shares at 765p

 

e)

Date of the transaction

08 April 2022

f)

Place of the transaction

London Stock Exchange, AIM market (XLON)

 

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Clare Filby

7.

Reason for the Notification

a)

Position/status

PDMR

b)

Initial notification/Amendment

Initial Notification

8.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Elixirr International plc

b)

LEI

213800MKY7OHMVAKW681

9.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 0.005p each ("Ordinary Shares")

Identification code

GB00BLPHTX84

b)

Nature of the transaction

Sale of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

765p

13,743

d)

Aggregated information:

 

13,743 shares at 765p

 

e)

Date of the transaction

08 April 2022

f)

Place of the transaction

London Stock Exchange, AIM market (XLON)

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Nicholas Willott

8.

Reason for the Notification

a)

Position/status

PDMR

b)

Initial notification/Amendment

Initial Notification

9.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Elixirr International plc

b)

LEI

213800MKY7OHMVAKW681

10.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 0.005p each ("Ordinary Shares")

Identification code

GB00BLPHTX84

b)

Nature of the transaction

Sale of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

765p

6,321

d)

Aggregated information:

 

6,321 shares at 765p

 

e)

Date of the transaction

08 April 2022

f)

Place of the transaction

London Stock Exchange, AIM market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSSMFIAEESESL
12
Date   Source Headline
24th Apr 20247:00 amRNSGrant of Share Options
22nd Apr 20247:00 amRNSFinal Results
8th Apr 20247:00 amRNSNotice of FY 23 Results and Investor Presentation
26th Jan 20247:00 amRNSDirector Dealing
8th Jan 20247:00 amRNSTrading Update and Change to Dividend Policy
11th Dec 20237:00 amRNSAcquisition of Insigniam LLC and Insigniam SAS
18th Sep 20237:00 amRNSInterim Results
18th Sep 20237:00 amRNSAcquisition of Responsum, Inc.
13th Jun 202310:45 amRNSResult of AGM
24th May 20231:31 pmRNSHolding(s) in Company
19th May 20237:00 amRNSPosting of Annual Report and Accounts
10th May 20233:00 pmRNSDirector/PCA Dealings
26th Apr 20237:00 amRNSGrant of Share Options
12th Apr 20237:00 amRNSAppointment of Joint Corporate Broker
4th Apr 20233:00 pmRNSDirector Dealing
3rd Apr 20239:15 amRNSDirector Dealing
3rd Apr 20237:00 amRNSFinal Results
28th Mar 20237:00 amRNSInvestor Presentation
27th Feb 20239:05 amRNSSecond Price Monitoring Extn
27th Feb 20239:00 amRNSPrice Monitoring Extension
27th Feb 20237:00 amRNSTrading Update
24th Feb 20232:05 pmRNSSecond Price Monitoring Extn
24th Feb 20232:00 pmRNSPrice Monitoring Extension
24th Feb 202311:05 amRNSSecond Price Monitoring Extn
24th Feb 202311:00 amRNSPrice Monitoring Extension
29th Nov 20221:15 pmRNSInvestor Presentation
11th Nov 20227:00 amRNSDirector Dealing
20th Oct 20227:00 amRNSPCA Dealing
6th Oct 20227:00 amRNSPurchase of Shares by Employee Benefit Trust
20th Sep 20227:00 amRNSInterim Results
12th Sep 20227:00 amRNSNotice of Interim Results
29th Jul 20224:41 pmRNSSecond Price Monitoring Extn
29th Jul 20224:35 pmRNSPrice Monitoring Extension
11th Jul 20221:45 pmRNSPDMR/PCA Dealing
7th Jul 202211:15 amRNSPCA Dealing
13th Jun 20221:00 pmRNSResult of AGM
19th May 20227:00 amRNSPosting of Annual Report & Accounts
29th Apr 20224:07 pmRNSResult of Secondary Placing
28th Apr 20224:06 pmRNSProposed Secondary Placing
8th Apr 20224:15 pmRNSDirector/PDMR Shareholding
4th Apr 20227:00 amRNSFinal Results
18th Mar 20227:00 amRNSAcquisition of iOLAP and FY2022 Earnings
1st Feb 20227:00 amRNSTrading Update
30th Nov 20217:00 amRNSDirector/PDMR Shareholding
13th Oct 202111:41 amRNSResult of Secondary Placing
13th Oct 20217:00 amRNSProposed Secondary Placing
27th Sep 20217:00 amRNSInterim Results
17th Jun 20218:13 amRNSDirector/PDMR Shareholding
16th Jun 202112:21 pmRNSResult of AGM
16th Jun 20217:00 amRNSAGM Statement
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.